Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 297

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Chronic Severe Uveitis: Etiology and Visual Outcome in 927 Patients from a Single Center

BODAGHI, BAHRAM, CASSOUX, NATHALIE, WECHSLER, BERTRAND, HANNOUCHE, DANIELE, FARDEAU, CHRISTINE, PAPO, THOMAS, HUONG, DU LE THI, PIETTE, JEAN-CHARLES, LEHOANG, PHUC · 2001 · Medicine

Abstract

Introduction There is a significant under-registration of blind and visually impaired patients attending ophthalmic departments. Blindness is defined by the World Health Organization (WHO) as the best possible corrected visual acuity in the better eye of less than 3/60 (20/400 or 0.05) or corresponding visual field ≤10°. Severe visual impairment is defined as the best-corrected visual acuity in the better eye of 3/60 (20/400 or 0.05) or more, but less than 6/60 (20/200 or 0.1) (40,49). In 1995, the WHO estimated that nearly 38 million people in the world were blind and 110 million had severe visual impairment. In 1997, the total number of estimated blind people was 44,800,000 (47). Causes of blindness can be classified according to different age-groups and geographic distribution (49). The major causes of blindness in the middle age-group in the Western world are tapetoretinal degeneration (20%), congenital abnormalities (20%), diabetes (20%), uveitis (10%), and accidents (5%) (17,21,25,44,48). Approximately 5%–20% of legal blindness in developed countries is due to uveitis (7,17,21,46). Uveitis is a potentially sight-threatening intraocular inflammation. Because of a variety of diagnostic criteria used by different centers, the epidemiology and etiologic distribution of uveitis have not been clearly defined. As a result, its incidence is reported to range from 17 per 100,000 to 24 per 100,000 residents, and its prevalence from 38 per 100,000 to 204 per 100,000 residents (7,23,24,38,51). Diagnostic workup determines an infectious etiology or an associated condition in about 60%-70% of cases of uveitis (13,15,16,22,30,41,42,50,52). Primary inflammatory disorders potentially associated with systemic manifestations or inflammatory conditions associated with infectious agents are most frequently reported. Infectious conditions are often associated with uveitis and blindness, especially in developing countries (6,31,32,49,53). Usual cases of uveitis, such as B27-associated disease or herpetic uveitis, are easily handled and are not usually referred to a tertiary eye care center. Most of these cases have a favorable evolution. In a number of complicated cases, the diagnosis is not easy to determine. The use of systemic antiinflammatory and immunosuppressive drugs is often justified and has considerably lowered the incidence of complications in these patients. These therapeutic applications are generally performed in specialized centers under the supervision of internists and ophthalmologists (35). We analyzed a series of 927 consecutive patients referred to our center between 1991 and 1996 for diagnostic and/or therapeutic management of severe uveitis. Therapeutic strategy was evaluated according to the level of intraocular inflammation, and the final visual outcome was determined. Patients and Methods The clinical records of all patients with severe or sight-threatening uveitis referred to the Ophthalmology Department of the Pitié-Salpêtrière Hospital, Paris, France, between January 1991 and January 1996 were retrospectively analyzed. Severe uveitis was defined based on the following criteria at the time of presentation: 1) visual acuity less than 20/100, 2) chronic uveitis (duration >3 months), 3) undiagnosed or unclassified cases after more than 2 different workups, and/or 4) uveitis requiring systemic antiinflammatory or immunosuppressive drugs. In all other cases, uveitis was not considered severe, and those patients were excluded. Furthermore, patients presenting with masquerade syndromes (intraocular lymphoma and postoperative or endogenous endophthalmitis) or infection in an immunosuppressed setting (cytomegalovirus retinitis) were excluded. In the latter, infectious or malignant conditions are highly predominant, and ocular inflammation is a secondary problem. On the other hand, cases of uveitis associated with other infectious diseases, such as toxoplasmic retinochoroiditis, Lyme disease, and syphilis or viral infections in immunocompetent patients, were included in this study. Immune disorders seem to play a major role in these conditions and should be treated in association with antiinfectious drugs. A minimal follow-up of 2 years was required for inclusion in the study to estimate final visual outcome. Classification of uveitis The International Uveitis Study Group (IUSG) classification (2), based on the ocular site of inflammation, was used throughout the study. Anterior uveitis was defined as the presence of anterior chamber inflammatory flare or cells associated with keratic precipitates and/or iris lesions, such as synechiae or partial atrophy. Since June 1991, anterior chamber inflammation was objectively quantified with a Laser Flare Cell Meter (KOWA 1000). Intermediate uveitis was defined as the presence of cells in the vitreous with or without the presence of inflammatory cell condensations in the anterior vitreous (snowballs) or the peripheral retina. The term “pars planitis” was used to des

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00005792-200107000-00005

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 297

Metadata

Authors
BODAGHI, B., CASSOUX, N., WECHSLER, B., HANNOUCHE, D., FARDEAU, C., PAPO, T., HUONG, D. L. T., PIETTE, J.-C., & LEHOANG, P.
Venue
Medicine
Published
2001-07
Volume
80
Issue
4
Pages
263-270
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2331990246
Cited by
297
References
24
FWCI
2.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic Severe Uveitis: Etiology and Visual Outcome in 927 Patients from a Single Center. https://app.cochat.ai/papers/10.1097/00005792-200107000-00005
The paper
BODAGHI, B., CASSOUX, N., WECHSLER, B., HANNOUCHE, D., FARDEAU, C., PAPO, T., HUONG, D. L. T., PIETTE, J.-C., & LEHOANG, P. (2001). Chronic Severe Uveitis: Etiology and Visual Outcome in 927 Patients from a Single Center. Medicine. https://doi.org/10.1097/00005792-200107000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.